Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Get Help Today

Looking for help or additional information? Contact us today.
First Name:
Last Name:
Email:
Phone:
Zip Code:
Comments:
Please enter the number below:
1156
Conditions: Cancer
Start Date: October 1, 2007
Phase: Phase III
Status: Completed
NCT ID: NCT00538850
Study Type: Interventional
Intervention: Drug: fentanyl sublingual spray|Other: questionnaire administration
Study Design: Allocation: Randomized|Control: Placebo Control|Masking: Double-Blind|Primary Purpose: Supportive Care
Results: No Results Available
Sponsors: Insys Therapeutics Inc
Ages: Adult|Senior
Enrollment: 130
Funded By: Industry
First Received: October 1, 2007
End Date:
Last Updated: November 4, 2010
Last Verified: November 1, 2010